Otulfi 130 mg concentrate for solution for infusion

Active Ingredient
Strength
  • Ustekinumab: 130 mg
Dosage Form
Concentrate for solution for infusion
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
SPC section shown.

Loading the document

Fresenius Kabi Ltd

Unit 3B Fingal Bay Business Park, Balbriggan, Co. Dublin, Ireland, K32YK12

Telephone
+35318413030